Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Drugs and Therapy
Metadata
Title
Cost-Effectiveness of Primary Implanted Cardioverter Defibrillator for Sudden Death Prevention in Congestive Heart Failure
Authors
Lei Chen
Joel W. Hay
Publication date
01-03-2004
Publisher
Kluwer Academic Publishers
Published in
Cardiovascular Drugs and Therapy / Issue 2/2004
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1023/B:CARD.0000029034.65769.f7

Other articles of this Issue 2/2004

Cardiovascular Drugs and Therapy 2/2004 Go to the issue

OriginalPaper

Different Effects of Exercise on Plasma Concentrations of Nebivolol, Bisoprolol and Carvedilol

OriginalPaper

A Description of the Clinical Characteristics at Baseline of Patients Recruited into the Carvedilol or Metoprolol European Trial (COMET)

Editorial Introduction

Do Pharmacological Differences Among Beta-Blockers Affect Their Clinical Efficacy in Heart Failure?

OriginalPaper

Omapatrilat Limits Infarct Size and Lowers the Threshold for Induction of Myocardial Preconditioning Through a Bradykinin Receptor-Mediated Mechanism

OriginalPaper

Nitric Oxide Synthase (NOS) Does Not Contribute to Simulated Ischaemic Preconditioning in an Isolated Rat Cardiomyocyte Model

OriginalPaper

Acetaminophen and Experimental Acute Myocardial Infarction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits